Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Renalytix Plc (RENX) Share Price

Intraday
Historical

Price	6.25p on 09-01-2026 at 13:00:08
Change	0.00p 0%
Buy	6.50p
Sell	6.00p

Last Trade:	Sell 1,300.00 at 6.00p
Day's Volume:	71,728
Last Close:	6.25p
Open:	6.25p
ISIN:	GB00BYWL4Y04

Day's Range	6.25p - 6.25p
52wk Range:	5.75p - 12.25p
Market Capitalisation:	£27.31m
VWAP:	6.129606p
Shares in Issue:	437.02m

Sector: Health Care and Related Services

Listed In: FTSE AIM All-Share,

Buy/Sell	Volume	Trade Prc	Trade Type	Trade Time
Renalytix Plc (RENX) Latest Trades
Sell*	1,300	6.00p	Ordinary	12:10:00 - 09-Jan-26
Sell*	16,595	6.05p	Ordinary	10:52:34 - 09-Jan-26
Sell*	1,333	6.05p	Ordinary	09:22:59 - 09-Jan-26
Sell*	50,000	6.15p	Ordinary	08:32:06 - 09-Jan-26
Buy*	2,500	6.36p	Ordinary	08:00:14 - 09-Jan-26
Buy*	414	6.28p	Ordinary	15:51:26 - 08-Jan-26
Sell*	16,636	6.0351p	Ordinary	15:26:17 - 08-Jan-26
Sell*	17,594	6.0351p	Ordinary	09:33:30 - 08-Jan-26
Buy*	64,636	6.1885p	Ordinary	09:33:11 - 08-Jan-26
Buy*	80	6.465p	Ordinary	09:26:39 - 08-Jan-26

See more Renalytix Plc trades

Renalytix Plc (RENX) Share Price History
Time period: to
Date	Open	High	Low	Close	Volume
9th Jan 2026 (Fri)	6.25	6.25	6.25	6.25	71,728
8th Jan 2026 (Thu)	5.90	6.25	5.90	6.25	273,982
7th Jan 2026 (Wed)	5.90	5.90	5.90	5.90	153,990
6th Jan 2026 (Tue)	5.90	5.90	5.90	5.90	107,835
5th Jan 2026 (Mon)	5.90	5.90	5.90	5.90	410,060
2nd Jan 2026 (Fri)	5.90	5.90	5.90	5.90	193,360
1st Jan 2026 (Thu)	5.90	5.90	5.90	5.90	0
31st Dec 2025 (Wed)	5.90	5.90	5.90	5.90	620,320
30th Dec 2025 (Tue)	5.90	6.00	6.00	6.00	91,363
29th Dec 2025 (Mon)	5.90	5.80	5.80	5.80	561,166
26th Dec 2025 (Fri)	5.90	5.90	5.90	5.90	0
25th Dec 2025 (Thu)	5.90	5.90	5.90	5.90	0
24th Dec 2025 (Wed)	5.90	5.90	5.90	5.90	200,317
23rd Dec 2025 (Tue)	6.25	6.25	5.75	5.90	1,867,540
22nd Dec 2025 (Mon)	6.25	6.25	6.25	6.25	558,418
19th Dec 2025 (Fri)	6.25	6.25	6.25	6.25	44,840
18th Dec 2025 (Thu)	6.25	6.25	6.00	6.00	3,253,118
17th Dec 2025 (Wed)	6.25	6.25	6.25	6.25	637,515
16th Dec 2025 (Tue)	6.25	6.25	6.25	6.25	223,355
15th Dec 2025 (Mon)	6.25	6.25	6.25	6.25	431,431
12th Dec 2025 (Fri)	6.25	6.25	6.25	6.25	64,369
11th Dec 2025 (Thu)	6.25	6.25	6.25	6.25	98,386
10th Dec 2025 (Wed)	6.25	6.25	6.25	6.25	222,685
9th Dec 2025 (Tue)	6.75	6.75	6.25	6.25	2,827,141

See more Renalytix Plc price history

Date	Source	Headline
Renalytix Plc (RENX) Regulatory News
6th Jan 2026 4:28 pm	RNS	Holding(s) in Company
24th Dec 2025 12:56 pm	RNS	Holding(s) in Company
24th Dec 2025 12:56 pm	RNS	Holding(s) in Company
23rd Dec 2025 4:13 pm	RNS	Holding(s) in Company
23rd Dec 2025 4:13 pm	RNS	Holding(s) in Company
19th Dec 2025 12:18 pm	RNS	Holding(s) in Company
19th Dec 2025 12:18 pm	RNS	Holding(s) in Company
17th Dec 2025 1:42 pm	RNS	Holding(s) in Company
16th Dec 2025 1:51 pm	RNS	Holding(s) in Company
9th Dec 2025 10:57 am	RNS	Result of AGM

See more Renalytix Plc regulatory news

Renalytix Plc (RENX) Share News

AIM WINNERS & LOSERS: MediaZest expects full-year earnings boost

9th Dec 2025 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: Life Science REIT hires former Hipgnosis Songs Fund chair

3rd Dec 2025 12:11

Life Science REIT PLC - real estate investment trust for UK properties leased to tenants in the life science sector - Hires Robert Naylor to be senior independent director, starting on Wednesday. Naylor replaces Richard Howell as senior director, but Howell will remain a non-executive director. Naylor previously was chair of both Hipgnosis Songs Fund Ltd and peer Round Hill Music Royalty Fund Ltd. He currently is chair of Aquila European Renewables PLC and is a non-executive director of PRS REIT PLC, Niox Group PLC and Renalytix PLC. As an executive, Naylor is lead fund manager for Achilles Investment Co Ltd. He previously worked at JP Morgan Asset Management, Panmure Gordon and Cenkos Securities. Read More

IN BRIEF: Aquila European Renewables appoints Robert Naylor as chair

28th Nov 2025 16:10

Aquila European Renewables PLC - managed by Aquila Capital, invests in European renewable energy assets - Appoints Robert Naylor as non-executive chair, effective Friday this week. Confirms Non-Executive Chair Ian Nolan has retired from the board as of Thursday, having served in his role since prior to the IPO in 2019. Aquila highlights Naylor's 29 years of experience in capital markets, with him specialising in the investment trusts sector. Notes his current position as lead fund manager at Achilles Investment Company Ltd, and NED at PRS REIT PLC, Niox Group PLC and Renalytix PLC. Read More

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition

12th Nov 2025 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

IN BRIEF: Renalytix loss narrows as costs down amid fewer employees

3rd Nov 2025 12:20

Renalytix PLC - London-based diagnostics company - Pretax loss narrows to USD21.8 million in the financial year ended June 30, from USD45.5 million a year prior. Revenue climbs 30% to USD3.0 million from USD2.3 million, with the company citing revenue growth across all revenue streams, as well as additional integration with a large physician practice in New York and increased pharma services revenue from global pharma leaders. Administrative costs reduce by 40% to USD18.4 million from USD30.7 million. This was "driven by headcount and operations optimization, delisting from NASDAQ, and the regaining foreign private issuer status. While reorganisation and delisting costs were higher than anticipated, the resulting reduction has provided a lower, predictable cash burn profile." Looking ahead, Renalytix says it continued to strengthen its presence in its initial three target states of Florida, Texas and New York. The company expects to announce additional complimentary strategic agreements in the current financial year running til the end of June 2026. Read More

See more Renalytix Plc news

FTSE 100 Latest

Value10,105.03

Change60.34

Renalytix Plc (RENX) Share Price

Login to your account